These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8177532)

  • 1. Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain.
    Kida E; Golabek AA; Wisniewski T; Wisniewski KE
    Neurosci Lett; 1994 Feb; 167(1-2):73-6. PubMed ID: 8177532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study.
    Shao Y; Gearing M; Mirra SS
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):376-81. PubMed ID: 9100668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain.
    Kida E; Choi-Miura NH; Wisniewski KE
    Brain Res; 1995 Jul; 685(1-2):211-6. PubMed ID: 7583250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.
    Namba Y; Tomonaga M; Kawasaki H; Otomo E; Ikeda K
    Brain Res; 1991 Feb; 541(1):163-6. PubMed ID: 2029618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits.
    Navarro A; Del Valle E; Astudillo A; González del Rey C; Tolivia J
    Exp Neurol; 2003 Dec; 184(2):697-704. PubMed ID: 14769361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ApoE immunoreactivity and microglial cells in Alzheimer's disease brain.
    Uchihara T; Duyckaerts C; He Y; Kobayashi K; Seilhean D; Amouyel P; Hauw JJ
    Neurosci Lett; 1995 Jul; 195(1):5-8. PubMed ID: 7478253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycation and microglial reaction in lesions of Alzheimer's disease.
    Dickson DW; Sinicropi S; Yen SH; Ko LW; Mattiace LA; Bucala R; Vlassara H
    Neurobiol Aging; 1996; 17(5):733-43. PubMed ID: 8892346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain.
    Snow AD; Sekiguchi RT; Nochlin D; Kalaria RN; Kimata K
    Am J Pathol; 1994 Feb; 144(2):337-47. PubMed ID: 8311117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pattern of beta-amyloid, amyloid precursor protein and apolipoprotein E expression in cortical senile plaques.
    Thal DR; Glas A; Schneider W; Schober R
    Acta Neuropathol; 1997 Sep; 94(3):255-65. PubMed ID: 9292695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low amyloid (Abeta) plaque load and relative predominance of diffuse plaques distinguish argyrophilic grain disease from Alzheimer's disease.
    Tolnay M; Calhoun M; Pham HC; Egensperger R; Probst A
    Neuropathol Appl Neurobiol; 1999 Aug; 25(4):295-305. PubMed ID: 10476046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study on the deposition of apolipoprotein E in cerebral and islet amyloidoses in cynomolgus monkeys (Macaca fascicularis).
    Nakamura S; Kiatipattanasakul W; Nakayama H; Ono F; Sakakibara I; Yoshikawa Y; Goto N; Doi K
    Exp Anim; 1996 Apr; 45(2):199-203. PubMed ID: 8726148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-localization of cholesterol, apolipoprotein E and fibrillar Abeta in amyloid plaques.
    Burns MP; Noble WJ; Olm V; Gaynor K; Casey E; LaFrancois J; Wang L; Duff K
    Brain Res Mol Brain Res; 2003 Jan; 110(1):119-25. PubMed ID: 12573540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease.
    Harr SD; Uint L; Hollister R; Hyman BT; Mendez AJ
    J Neurochem; 1996 Jun; 66(6):2429-35. PubMed ID: 8632166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease.
    Styren SD; Kamboh MI; DeKosky ST
    J Comp Neurol; 1998 Jul; 396(4):511-20. PubMed ID: 9651008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ripellino JA; Li Y; Schmidt SD; Mathews PM; Fryer JD; Holtzman DM; Sigurdsson EM; Wisniewski T
    Am J Pathol; 2004 Sep; 165(3):937-48. PubMed ID: 15331417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease.
    Gearing M; Schneider JA; Robbins RS; Hollister RD; Mori H; Games D; Hyman BT; Mirra SS
    J Neuropathol Exp Neurol; 1995 Nov; 54(6):833-41. PubMed ID: 7595656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis.
    Wisniewski T; Golabek AA; Kida E; Wisniewski KE; Frangione B
    Am J Pathol; 1995 Aug; 147(2):238-44. PubMed ID: 7639323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.